drugset / Trial / NCT07307274
A Study of SYNT-101 to Test Safety, Tolerability and Pharmacodynamics of SYNT-101 in Healthy and Overweight Adults
RandomizedSequentialDouble-blindTreatment
Summary
A Phase 1, single-center, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and pharmacodynamics of single and multiple dose regimens of SYNT-101 in healthy and overweight adults.
Timeline
- Start
- 2026-01-13
- Primary completion
- 2026-10
- Completion
- 2026-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | SYNT101 | Unknown | — | — |
Indications
No indication recorded.